WALTHAM, Massachusetts--Interleukin Genetics, Inc. has announced that Dr. Kenneth Kornman will present June 6, 2008, at the 13th International Conference on Periodontal Research in Ljubljana, Slovenia.
Dr. Kornman, chief scientific officer of Interleukin Genetics, will speak on the genetic and environmental factors that control inflammation differences among individuals.
The ICPR meeting has been held approximately every three years since 1969 to bring together world leaders in periodontal research to reassess the current knowledge in the field and to identify new research direction, as well as to improve the diagnosis, prevention, and treatment of periodontal diseases.
Periodontitis is a bacterially induced chronic inflammatory disease that causes destruction of bone and other tissues that support the teeth. Severe periodontitis, which usually leads to loss of multiple teeth, is found in approximately 8-13% of the adult population.
The presence and severity of periodontitis have been associated with an increased risk for other important inflammatory conditions, including pre-term births, cardiovascular disease, rheumatoid arthritis, and certain cancers.
WHO: Dr. Kenneth Kornman, chief scientific officer of Interleukin Genetics
WHERE: 13th International Conference on Periodontal Research in Ljubljana, Slovenia
WHEN: Friday, June 6, 2008, from 9:45-10:30 GMT
WHAT: Approximately 30-60% of the severity of periodontal disease is determined by genetics. Interleukin Genetics developed and markets the PST genetic test to help identify individuals at increased risk for severe periodontal disease and complications from dental implants. This test helps dentists guide the management of their patients' periodontal disease to avoid complications of severe periodontitis.
For more information about Interleukin, its products and ongoing programs, visit Interleukin Genetics.
To read more about this subject, go to Biodontics.
To comment on this topic, go to PennWell Dental Community site.
